secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001079973-26-000377
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc FY 2025 revenue up 6% to $9.027M; net loss widens to $2.47M on deferred tax charge
--------------------------------------------------------------------------------

- Revenue $9.027M (+6% YoY); net loss $2.470M ($0.90/diluted share) vs $1.053M loss in 2024.
- Gross margin stable at 40.3%; pre-tax loss improved to $1.311M from $1.405M.
- Deferred tax valuation allowance increased to $1.738M (non-cash) from $187K.
- SpinDetect drug analyzer: production mold fabrication started Q1 2026; first articles expected April.
- New L-series breath testers (LX9, LT7) certified to AS 3547:2019; driving market penetration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997326000377/0001079973-26-000377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997326000377/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-26-000377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer